Key result
The study identified a single potentially pathogenic change in CACNA1S among malignant hyperthermia patients, but found no categorical evidence that CACNA1S haplotypes are a major risk factor.
Why the study?
Does the CACNA1S gene play a major role in malignant hyperthermia susceptibility in the UK?
Observational (n=940)
No
Does the CACNA1S gene play a major role in malignant hyperthermia susceptibility in the UK?
Answers are grounded in this paper and cite their sources.
CACNA1S mutations may play a role in malignant hyperthermia susceptibility, but the haplotype structure is highly variable.
BACKGROUND: Malignant hyperthermia (MH) is an inherited pharmacogenetic disorder of skeletal muscle, characterised by an elevated calcium release from the skeletal muscle sarcoplasmic reticulum. The dihydropyridine receptor (DHPR) plays an essential role in excitation-contraction coupling and calcium homeostasis in skeletal muscle. This study focuses on the gene CACNA1S which encodes the alpha1 subunit of the DHPR, in order to establish whether CACNA1S plays a major role in MH susceptibility in the UK. METHODS: We investigate the CACNA1S locus in detail in 50 independent MH patients, the largest study to date, to identify novel variants that may predispose to disease and also to characterise the haplotype structure across CACNA1S. RESULTS: We present CACNA1S cDNA sequencing data from 50 MH patients in whom RYR1 mutations have been excluded, and subsequent mutation screening analysis. Furthermore we present haplotype analysis of unphased CACNA1S SNPs to (1) assess CACNA1S haplotype frequency differences between susceptible MH cases and a European control group and (2) analyse population-based association via clustering of CACNA1S haplotypes based on disease risk. CONCLUSION: The study identified a single potentially pathogenic change in CACNA1S (p.Arg174Trp), and highlights that the haplotype structure across CACNA1S is diverse, with a high degree of variability.
No takes yet. Share an insight, caveat, or question.
Carpenter et al. (2009) conducted an observational in Malignant hyperthermia (n=940). CACNA1S gene variants vs. Population controls was evaluated on CACNA1S haplotype frequency differences between malignant hyperthermia susceptible cases and population controls (p=0.02). The study identified a single potentially pathogenic change in CACNA1S among malignant hyperthermia patients, but found no categorical evidence that CACNA1S haplotypes are a major risk factor.
Synapse has enriched 10 related papers. Consider them for comparative context: